Catherine W.

Snr. Director Clinical Operations Europe at Trevi Therapeutics

Catherine W. has a wealth of work experience, beginning in 1998 as a Pharmaceutical Sales Representative for Eli Lilly and Company. Catherine then worked as a Clinical Trial Coordinator for the National Health Sciences Center, Canberra Hospital in 2000. From 2002 to 2004, they worked as a Coordinator for the Diabetes Registry at SENSWDGP. In 2004, they became a Clinical Project Manager at Genzyme Europe BV. Catherine then moved to Grünenthal in 2008 as a Global Clinical Study Manager. In 2009, they began working at Baxter BioScience as a Senior Manager, Clinical and then as a Senior Manager, External Partnerships at Baxalta from 2015 to 2017. Finally, from 2017 to 2019, they were a Consultant and Owner at Alluro Co and then a Snr. Director Clinical Operations Europe at Trevi Therapeutics, Inc.

Catherine W. began their educational journey in 1996 when they attended the University of Canberra to pursue a Bachelor of Applied Science in Nutritional Science, which they completed in 1998. Catherine then returned to the University of Canberra in 2002 to earn a Graduate Certificate in Clinical Research Management. In 2015, they attended Harvard Extension School to earn a Graduate Certificate in Business Communication, which they completed in 2016.

Location

Canberra, Australia

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Trevi Therapeutics

1 followers

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.


Employees

11-50

Links